Onasemnogene Abeparvovec Gene Therapy in Presymptomatic spinal muscular atrophy (SMA): SPR1NT study update in children with 3 Copies of SMN2

被引：2

作者：

Strauss, K. ^{[1
]}

Muntoni, F. ^{[2
]}

Farrar, M. ^{[3
]}

Saito, K. ^{[4
]}

Mendell, J. ^{[5
]}

Servais, L. ^{[6
]}

McMillan, H. ^{[7
]}

Swoboda, K. ^{[8
]}

Kwon, J. ^{[9
]}

Zaidman, C. ^{[10
]}

Chiriboga, C. ^{[11
]}

Iannaccone, S. ^{[12
]}

Krueger, J. ^{[13
]}

Parsons, J. ^{[14
]}

Shieh, P. ^{[15
]}

Kavanagh, S. ^{[16
]}

Chand, D. ^{[16
]}

Tauscher-Wisniewski, S. ^{[16
]}

Macek, T. ^{[16
]}

机构：

[1] Clin Special Children, Strasburg, PA USA

[2] UCL, London, England

[3] Sydney Childrens Hosp Network, Randwick, NSW, Australia

[4] Tokyo Womens Med Univ, Tokyo, Japan

[5] Nationwide Childrens Hosp, Columbus, OH USA

[6] MDUK Oxford Neuromuscular Ctr, Oxford, England

[7] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada

[8] Massachusetts Gen Hosp, Boston, MA 02114 USA

[9] Univ WI, Sch Med & Publ Hlth, Madison, WI USA

[10] Washington Univ, Sch Med, St Louis, MO USA

[11] Columbia Univ, Med Ctr, New York, NY USA

[12] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA

[13] Helen DeVos Childrens Hosp, Grand Rapids, MI USA

[14] Univ Colorado, Sch Med, Aurora, CO USA

[15] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

[16] Novartis Gene Therapies, Bannockburn, IL USA

来源：

NEUROMUSCULAR DISORDERS | 2021年 / 31卷

关键词：

D O I：

10.1016/j.nmd.2021.07.299

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EP.274

引用

页码：S133 / S133

页数：1

共 50 条

[41] Onasemnogene abeparvovec gene therapy for spinal muscular atrophy: A cohort study from the United Arab Emirates
Mundada, Vivek
Narayan, Omendra
Arora, Siddharth
Beri, Nidhi
Abusamra, Rania
Mullasery, Deepak
Parashar, Deepak
MUSCLE & NERVE, 2024, 70 (04) : 808 - 815
[42] SMN2 gene promoter methylation: implications for progression and therapy of spinal muscular atrophy
Hauke, J.
Wirth, B.
Hahnen, E.
JOURNAL OF NEUROLOGY, 2008, 255 : 67 - 67
[43] Real-world experience of delivering gene-therapy with onasemnogene abeparvovec (Zolgensma®) for children with spinal muscular atrophy (SMA) type-1 in the UK
Gowda, V
Jungbluth, H.
Standing, E.
Sheehan, J.
Hughes, I
Mccullagh, G.
Atherton, M.
Ong, M.
Majumdar, A.
Murugan, A.
Dhawan, A.
Muntoni, F.
Baranello, G.
Scoto, M.
Manzur, A.
Munot, P.
Abbot, L.
Horrocks, I
Tirupathi, S.
Wraige, E.
NEUROMUSCULAR DISORDERS, 2022, 32
[44] Onasemnogene abeparvovec gene replacement therapy for the treatment of spinal muscular atrophy: a real-world observational study
Ilaria Bitetti
Valentina Lanzara
Giovanna Margiotta
Antonio Varone
Gene Therapy, 2023, 30 : 592 - 597
[45] Intrathecal Administration of Onasemnogene Abeparvovec Gene-Replacement Therapy (GRT) for Spinal Muscular Atrophy Type 2 (SMA2): Phase 1/2a Study (STRONG)
Finkel, R.
Day, J.
Darras, B.
Kuntz, N.
Connolly, A.
Crawford, T.
Butterfield, R.
Shieh, P.
Tennekoon, G.
Iannaccone, S.
Ogrinc, F.
Kavanagh, S.
Kernbauer, E.
Whittle, J.
L'Italien, J.
Kaspar, B.
Sproule, D.
Spector, S.
Feltner, D.
Mendell, J.
ANNALS OF NEUROLOGY, 2019, 86 : S30 - S30
[46] Intrathecal administration of onasemnogene abeparvovec gene-replacement therapy (GRT) for spinal muscular atrophy type 2 (SMA2): phase 1/2a study (STRONG)
Finkel, R.
Day, J.
Darras, B.
Kuntz, N.
Connolly, A.
Crawford, T.
Butterfield, R.
Shieh, P.
Tennekoon, G.
Iannaccone, S.
Ogrinc, F.
Kavanagh, S.
Kernbauer, E.
Whittle, J.
L'Italien, J.
Kaspar, B.
Sproule, D.
Spector, S.
Feltner, D.
Mendell, J.
NEUROMUSCULAR DISORDERS, 2019, 29 : S207 - S207
[47] Interim results from RESPOND: a study of nusinersen in children with spinal muscular atrophy (SMA) previously treated with onasemnogene abeparvovec (OA)
Masson, R.
Proud, C.
Finkel, R.
Parsons, J.
Kuntz, N.
Foster, R.
Li, W.
Chary, S.
Sohn, J.
Fradette, S.
Youn, B.
Paradis, A.
NEUROMUSCULAR DISORDERS, 2024, 43
[48] Ethical issues related to gene therapy with onasemnogene abeparvovec for spinal muscular atrophy type 1 in a developing country
Thong, Meow-Keong
Tae, Sok-Kun
Mazlan, Rifhan
Fong, Choong Yi
Marie, Nathan Anna
Li, Limin
Lim, Wei-Kang
Eg, Kah-Peng
GENETICS IN MEDICINE, 2022, 24 (03) : S274 - S275
[49] AVXS-101 Gene-Replacement Therapy (GRT) in Presymptomatic Spinal Muscular Atrophy (SMA): Study Update
Schultz, Meredith
Swoboda, Kathryn
Farrar, Michelle
McMillan, Hugh
Parsons, Julie
Wells, Courtney
Ogrinc, Francis G.
McGill, Bryan
Feltner, Douglas E.
L'Italien, James
Sproule, Douglas M.
Strauss, Kevin A.
NEUROLOGY, 2019, 92 (15)
[50] Onasemnogene abeparvovec gene replacement therapy for the treatment of spinal muscular atrophy: a real-world observational study
Bitetti, Ilaria
Lanzara, Valentina
Margiotta, Giovanna
Varone, Antonio
GENE THERAPY, 2023, 30 (7-8) : 592 - 597

← 1 2 3 4 5 →